available for iOS, Android & web
January 18, 2013
UK minister for science bats for AstraZeneca and says firm could shed even more jobs if its new drug doesn’t see better uptake
July 17, 2012
AstraZeneca's ousted chief executive David Brennan waived any claim to a bonus for the five months of 2012 before he resigned from the company
April 26, 2012
As it posted disappointing sales and earnings for the first quarter, AstraZeneca has announced that chief executive David Brennan is to retire, amid pressure from disgruntled shareholders
April 16, 2012
AstraZeneca’s chief executive David Brennan has maintained he will be staying in the top role despite speculation surrounding the company’s future.
International Clinical Researcher of the Year 2016
Last chance to enter!
PharmaTimes 2015 Copyright | RSS Feed Subscriptions